Skip to Content

WATSON 3219 (Aspirin, Butalbital and Caffeine 325 mg / 50 mg / 40 mg)

Pill with imprint WATSON 3219 is Green & Yellow, Capsule-shape and has been identified as Aspirin, Butalbital and Caffeine 325 mg / 50 mg / 40 mg. It is supplied by Watson Pharmaceuticals.

Aspirin/butalbital/caffeine is used in the treatment of migraine; pain; headache and belongs to the drug class analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine 325 mg / 50 mg / 40 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 3219

Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219
Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219
Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219

Aspirin, Butalbital and Caffeine

Imprint:
WATSON 3219
Strength:
325 mg / 50 mg / 40 mg
Color:
Green & Yellow
Size:
29.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Analgesic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
3 - Moderate abuse potential
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
microcrystalline cellulose
corn starch
magnesium silicate
D&C Yellow No. 10
FD&C Green No. 3
gelatin
ferric oxide red
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0934 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide